The Patent Finder

Mass Spectrometry Assay for Congenital Adrenal Hyperplasia

Quest Diagnostics Investments LLC

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 10 of these applications claim priority to application 61/140,824, filed Dec 24, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 8,415,616Mass Spectrometry Assay for Congenital Adrenal Hyperplasia
In force
 · High confidence
UsedRemaining
Quest Diagnostics Investments IncorporatedIn forceHigh confidence
US 8,674,291Mass Spectrometry Assay for Congenital Adrenal Hyperplasia
In force
 · High confidence
Quest Diagnostics Investments IncorporatedIn forceHigh confidence
US 9,057,732Mass Spectrometry Assay for Congenital Adrenal Hyperplasia
In force
 · High confidence
Quest Diagnostics Investments Inc.In forceHigh confidence
US 9,541,562Mass Spectrometry Assay for Congenital Adrenal Hyperplasia
In force
 · High confidence
Quest Diagnostics Investments IncorporatedIn forceHigh confidence
US 9,921,231Mass Spectrometry Assay for Congenital Adrenal Hyperplasia
In force
 · High confidence
Quest Diagnostics Investments IncorporatedIn forceHigh confidence
US 10,429,396Mass Spectrometry Assay for Congenital Adrenal Hyperplasia
In force
 · High confidence
Quest Diagnostics Investments IncorporatedIn forceHigh confidence
US 10,697,980Mass Spectrometry Assay for Congenital Adrenal Hyperplasia
In force
 · High confidence
Quest Diagnostics Investments IncorporatedIn forceHigh confidence
US 10,948,501Mass Spectrometry Assay for Congenital Adrenal Hyperplasia
In force
 · High confidence
Quest Diagnostics Investments IncorporatedIn forceHigh confidence
US 12,196,765Mass Spectrometry Assay for Congenital Adrenal Hyperplasia
In force
 · High confidence
Quest Diagnostics Investments IncorporatedIn forceHigh confidence
US 8,153,962Mass Spectrometry Assay for Congenital Adrenal Hyperplasia
In force
 · High confidence
Quest Diagnostics Investments LLCIn forceHigh confidence
2 more records in this group · Pro
10 of 12 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 12.
Upgrade to Pro
10 of these are in force and held by Quest Diagnostics Investments LLC.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited